Get started
Author

Ingrid Menkyová

Observed names: I Menkyova, I Menkyová, I. Menkyova, Ingrid Menkyova, Menkyova, I., Menkyova, Ingrid
ORCID: 0000-0002-4164-7471
Observed ORCID: 0000-0002-4164-7471
OpenAlex ID: A5015101284
To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
2022 · Dominika Stastna, Ingrid Menkyova, et al. · Multiple Sclerosis and Related Disorders · 40
PDF
Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia
2021 · Dominika Stastna, Ingrid Menkyova, et al. · Multiple Sclerosis and Related Disorders · 31
PDF
The Czech National MS Registry (ReMuS): Data trends in multiple sclerosis patients whose first disease-modifying therapies were initiated from 2013 to 2021
2023 · Dominika Stastna, Jiri Drahota, et al. · Biomedical Papers · 22
PDF
Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
2023 · Petra Nytrova, Dominika Stastna, et al. · Frontiers in Immunology · 14
PDF
Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis
2022 · Michaela Andelova, Karolina Vodehnalova, et al. · BMC Neurology · 9
PDF
Validation of the Czech Version of the Dysphagia in Multiple Sclerosis Questionnaire (DYMUS)
2022 · Klára Novotná, Jiří Motýl, et al. · Dysphagia · 7
PDF
Effect of Tai-chi on balance, mood, cognition, and quality of life in women with multiple sclerosis: A one-year prospective study
2023 · Ingrid Menkyova, Dominika Stastna, et al. · EXPLORE · 6
Differences in physical activity between individuals with multiple sclerosis and healthy adults in Central Europe
2025 · R Vetrovska, B Kosova, et al. · Multiple Sclerosis and Related Disorders · 5
High efficacy treatment since the first attack - an important step in the treatment of multiple sclerosis?
2023 · Dominika Šťastná, Ingrid Menkyová, et al. · Neurologie pro praxi · 5
PDF
Effectiveness of tixagevimab/cilgavimab (Evusheld) in antiCD20‑treated patients with multiple sclerosis and neuromyelitis optica spectrum disorder
2024 · D. Stastna, M. Vachova, et al. · Multiple Sclerosis and Related Disorders · 3
Internal comorbidities and complications of multiple sclerosis therapy -don't be caught off guard!
2023 · Dominika Šťastná, Jana Seňavová, et al. · Vnitřní lékařství · 3
PDF
SARS ‐ CoV ‐2 Is Linked to Brain Volume Loss in Multiple Sclerosis
2025 · Tomas Uher, Dominika Stastna, et al. · Annals of Clinical and Translational Neurology · 2
PDF
Positive Effect of a Cooling Cap on Functional Performance in Thermosensitive People with Multiple Sclerosis: A Randomized Controlled Trial
2024 · K. Novotna, K. Dedinova, et al. · Acta Neurologica Scandinavica · 2
PDF
Balance disorders in patients with multiple sclerosis and possible rehabilitation therapy – current findings from controlled clinical trials
2022 · Klára Novotná, Ingrid Menkyová, et al. · Česká a slovenská neurologie a neurochirurgie · 2
Despite the COVID-19 Pandemic, People with Chronic Neurological Disease (Multiple Sclerosis) are Trying to Maintain Physical Activity
2023 · Klára Novotná, Renata Větrovská, et al. · Studia sportiva · 1
PDF
McDonald 2024 diagnostic criteria for multiple sclerosis in a nutshell – a neurologist’s and radiologist’s perspective
2026 · Dominika Šťastná, Pavel Ryška, et al. · Česká a slovenská neurologie a neurochirurgie
The Role of T Cells in Multiple Sclerosis: Molecular Mechanisms, Drivers, and Therapeutic Targets
2026 · Pavel Potuznik, Jakub Vejskal, et al. · Journal of Integrative Neuroscience
PDF
Post COVID challenges in chronic neurological conditions: exploring perceived symptoms and the potential effect of individual physiotherapy
2025 · Klára Novotná, Kristýna Dandová, et al. · Kontakt
PDF
From Trials to Real-world Data: National Insights on Cladribine Tablets in Multiple Sclerosis After Four Years and Beyond (P8-1.009)
2025 · Dominika Stastna, Gregor Fistravec, et al. · Neurology
Ravulizumab in treatment of AQP4-IgGpos Neuromyelitis Optica Spectrum Disorder
2024 · Petra Nytrová, Ingrid Menkyová · Neurologie pro praxi
Physiotherapy in patients with multiple sclerosis with more severe neurological deficit
2024 · Klára Novotná, Veronika Knapová, et al. · Neurologie pro praxi
PDF
Effectiveness of Tixagevimab/Cilgavimab (Evusheld) in AntiCD20 Treated Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder (P8-6.006)
2024 · Dominika Stastna, Marta Vachova, et al. · Neurology
Pády U Osob S Roztroušenou Sklerózou
2023 · I Menkyová, M Andělová, et al. · časopis REHABILITÁCIA
PDF
Corrigendum to ’To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection’[Multiple sclerosis and related disorders vol. 65 (2022) 104014]
2023 · Dominika Stastna, Ingrid Menkyova, et al. · Multiple Sclerosis and Related Disorders
PDF
Rehabilitation in post-Covid-19 patients (specifically those with multiple sclerosis)
2022 · Klára Novotná, Ingrid Menkyová, et al. · Neurologie pro praxi
Works count: 32
Citation count: 152
H-index: 6
I10-index: 4
Year
Topic
Type